Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Three effective treatments for COVID-19 not (yet) in guidelines

    Three effective treatments for COVID-19 not (yet) in guidelines

    FromLet's Talk ID

    Start listeningView podcast show

    Three effective treatments for COVID-19 not (yet) in guidelines

    FromLet's Talk ID

    ratings:
    Length:
    25 minutes
    Released:
    Mar 25, 2023
    Format:
    Podcast episode

    Description

    Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.
    Released:
    Mar 25, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    The Infectious Diseases Society of America's Guideline Update presents concise summaries of IDSA guidelines. For details of the guidelines, please go to www.idsociety.org .Host: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.